Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
Kribado icon

5.5.0 by Indigital Technologies LLP


Aug 25, 2024

About Kribado

Instantly provides a risk score for a patient.

The Kribado is the next generation risk stratification and behaviour setting device for Healthcare Practitioners (HCP) and Healthcare companies. A non-invasive screening protocol that instantly provides a risk score for a patient in the waiting room, making it possible to triage these patients to the relevant areas/procedures by early identification of risk. It is designed to eliminate data collection errors by structuring each screen so that it is easy to use with consistent data. The Kribado will assist physicians in treating patients by implementing a pre-admission risk strat. Kribado consists of a small touch-screen connected to a embeded printer, and operates using AI and risk scoring algorithms trained on perfect human data. The end result is that it helps alert the healthcare professionals to potential behavioral risk factors of each patient in waiting areas. It also gives each company an accurate overview of their surveys, phase IV studies and in-clinic camps.

What's New in the Latest Version 5.5.0

Last updated on Aug 25, 2024

New UI.
Printer auto connect.
Minor bug fixes.

Translation Loading...

Additional APP Information

Latest Version

Request Kribado Update 5.5.0

Uploaded by

Gamal ELdesoky

Requires Android

Android 5.0+

Available on

Get Kribado on Google Play

Show More

Kribado Screenshots

Comment Loading...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.